T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) Drugs in Development by Therapy Areas and Indications, Stages, ...
Published: May 2022 - Pages: 58
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4-Leu 3 or CD4) Drugs in Development by Therapy Areas and Indic...
Published: May 2022 - Pages: 49
Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 214
Follicular Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 323
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) Drugs in Development by Therapy Areas and Indicat...
Published: May 2022 - Pages: 67
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) Drugs in ...
Published: May 2022 - Pages: 48
Integrin Beta 3 (Platelet Membrane Glycoprotein IIIa or CD61 or ITGB3) Drugs in Development by Therapy Areas and Indicat...
Published: May 2022 - Pages: 57
Gastroesophageal (GE) Junction Carcinomas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Player...
Published: May 2022 - Pages: 142
TAR DNA Binding Protein 43 (TDP43 or TARDBP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Mo...
Published: May 2022 - Pages: 51
Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10....
Published: May 2022 - Pages: 36
Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) Drugs in Development by Therapy Areas and Indication...
Published: May 2022 - Pages: 79
DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) Drugs in Development by Therapy ...
Published: May 2022 - Pages: 40
Mycobacterium tuberculosis Protein Ag85A Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecu...
Published: May 2022 - Pages: 36
Wilms Tumor Protein (WT33 or WT1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type...
Published: May 2022 - Pages: 45
Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 131
Hyperlipidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 146
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) Drugs in Developm...
Published: May 2022 - Pages: 43
Leukocyte Surface Antigen CD47 (Antigenic Surface Determinant Protein OA3 or Integrin Associated Protein or Protein MER6...
Published: May 2022 - Pages: 127
Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) Drugs in Development by ...
Published: May 2022 - Pages: 35
GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, S...
Published: May 2022 - Pages: 159
